Fig. 3From: Clinical response to adding pyrotinib to pembrolizumab and lenvatinib for HER2-positive advanced intrahepatic cholangiocarcinoma: a case reportImages of the patient during treatment. Abbreviations: SD, stable disease; PD, progressive disease; PR, partial responseBack to article page